Desktop Site |
20 Sep 24 | 09:41 | Open
Equity SME Eq Drv Currency Commodity Corporates
Get Quote
Notices |
BSE SENSEX 83,323.93 +139.13 +0.17 %
Corporate Announcement
  • Security Code524804
    CompanyAurobindo Pharma Ltd
    Exchange Received Time12/11/2018 20:00:35
    Exchange Disseminated Time12/11/2018 20:00:41
    Time Taken00:00:06
     
     
     Announcement under Regulation 30 (LODR)-Acquisition | 11/12/18 20:00 
     Our wholly owned subsidiary, Aurobindo Pharma USA Inc., USA, has entered into an agreement to acquire a product under development and related assets from 'Advent Pharmaceuticals Pty Ltd., Australia, through AuroScience Pty Limited, Melbourne, a 100% subsidiary of Aurobindo Pharma USA Inc., USA. The disclosure pursuant to Regulation 30 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and Part A of Schedule III of the aforesaid regulations, is attached as 'Annexure A'. 
    AttachmentDownload PDF
     
    << Back  
     
Recently Viewed
Copyright@ 2015. All Rights Reserved. BSE Ltd.
(20H) 20 Sep 24|09:41 (IST)